BRIP1 and gastric adenocarcinoma: BRIP1 promoter methylation (median value > 40%) was observed in one to two cases of cervical squamous cell carcinoma (CESC), liver hepatocellular carcinoma (LIHC), STAD and UCEC (Supplementary Figure S2 and S5).